当前位置：
X-MOL 学术
›
Genet. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Assessment of plasma lyso-Gb 3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
Genetics in Medicine ( IF 8.8 ) Pub Date : 2020-11-20 , DOI: 10.1038/s41436-020-01041-5 Daniel G Bichet 1 , Johannes M Aerts 2 , Christiane Auray-Blais 3 , Hiroki Maruyama 4 , Atul B Mehta 5 , Nina Skuban 6 , Eva Krusinska 6 , Raphael Schiffmann 7
Genetics in Medicine ( IF 8.8 ) Pub Date : 2020-11-20 , DOI: 10.1038/s41436-020-01041-5 Daniel G Bichet 1 , Johannes M Aerts 2 , Christiane Auray-Blais 3 , Hiroki Maruyama 4 , Atul B Mehta 5 , Nina Skuban 6 , Eva Krusinska 6 , Raphael Schiffmann 7
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译：
更正：评估血浆 lyso-Gb 3 用于临床监测米加司他治疗的法布里病患者的治疗反应
本文的修订版已发布，可通过本文顶部的链接访问。
更新日期：2020-11-21
中文翻译：
更正：评估血浆 lyso-Gb 3 用于临床监测米加司他治疗的法布里病患者的治疗反应
本文的修订版已发布，可通过本文顶部的链接访问。
京公网安备 11010802027423号